Predictive Value of Prostate-specific Antigen, Tumour Stage and Tumour Grade for the Outcome of Bone Scintigraphy in Patients with Newly Diagnosed Prostate Cancer-Reference-Cited by-同舟云学术

Predictive Value of Prostate-specific Antigen, Tumour Stage and Tumour Grade for the Outcome of Bone Scintigraphy in Patients with Newly Diagnosed Prostate Cancer

Published:1999-01-01 Issue:2 Volume:33 Page:89-93
ISSN:0036-5599
Container-title:Scandinavian Journal of Urology and Nephrology
language:en
Short-container-title:Scandinavian Journal of Urology and Nephrology

Author:

Anders Rydh, Radisa Tomic, Björn Tavelin, Sven-Ola Hietala, ¹

Affiliation:

1. From the Departments of Diagnostic Radiology, Urology and Oncology, University Hospital of Northern Sweden, Umea, Sweden

Publisher

Informa UK Limited

Subject

Urology,Nephrology

Link

https://www.tandfonline.com/doi/pdf/10.1080/003655999750016041

Reference18 articles.

1. Oesterling JE. Using prostate-specific antigen to elim-inate unnecessary diagnostic tests: significant world-wide economic implications. Urology 1995; 46 Suppl A: 26–33.

2. Predicting Radionuclide Bone Scan Findings in Patients with Newly Diagnosed, Untreated Prostate Cancer: Prostate Specific Antigen is Superior to All Other Clinical Parameters

3. The clinical value of prostate-specific antigen and bone scintigraphy in the staging of patients with newly diagnosed, pathologically proven prostate cancer

4. Clinical Use of Prostate-Specific Antigen in the Staging of Patients with Prostatic Carcinoma

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Yield of bone scintigraphy for the detection of metastatic disease in treatment-naive prostate cancer: a systematic review and meta-analysis;Clinical Radiology;2018-02

2. Neoplastic Bone Diseases;Orthopedic Nuclear Medicine;2017

3. Nuclear Medicine (Bone Scan, Choline and PSMA PET/CT);Management of Prostate Cancer;2017

4. Bone Scan Is of Doubtful Value as a First Staging Test in the Primary Presentation of Prostate Cancer;ISRN Oncology;2012-11-05

5. Prostate Imaging Modalities that Can Be Used for Complementary and Alternative Medicine Clinical Studies;Urologic Clinics of North America;2011-08